<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00066144</url>
  </required_header>
  <id_info>
    <org_study_id>P50AT000155</org_study_id>
    <nct_id>NCT00066144</nct_id>
  </id_info>
  <brief_title>Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms</brief_title>
  <official_title>Black Cohosh and Red Clover Efficacy for the Relief of Menopausal Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Office of Dietary Supplements (ODS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Phase II study, a follow-up to a Phase I trial in normal volunteers, will determine the&#xD;
      efficacy of black cohosh and red clover for the relief of menopausal symptoms. It will also&#xD;
      assess the safety of chronic dosing (1 year) by evaluating uterine (endometrial biopsies),&#xD;
      breast (mammography), and hematology parameters (CBC and chemistry lab values) at baseline&#xD;
      and 1 year.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">April 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Hot Flashes</condition>
  <condition>Menopause</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cimicifuga racemosa</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trifolium pratense</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Black cohosh</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Red clover</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Menopausal women with intact uterus&#xD;
&#xD;
          -  Must be experiencing hot flashes&#xD;
&#xD;
          -  No menstrual periods for at least 6 months and no longer than 3 years&#xD;
&#xD;
          -  Non-smoker&#xD;
&#xD;
          -  Must have intact uterus (no hysterectomy)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications for hormone replacement therapy&#xD;
&#xD;
          -  Diabetes mellitus&#xD;
&#xD;
          -  Pregnancy or breast-feeding&#xD;
&#xD;
          -  Obese (BMI &gt;35 excluded)&#xD;
&#xD;
          -  History of endometrial hyperplasia/neoplasia/malignancy&#xD;
&#xD;
          -  History of breast or reproductive cancer&#xD;
&#xD;
          -  History of severe recurrent depression, or severe psychiatric disturbance&#xD;
&#xD;
          -  History of stroke/CVA, severe varicose veins, sickle cell anemia, myocardial&#xD;
             infarction (heart attack), or arrhythmia (rhythm disturbance of the heart)&#xD;
&#xD;
          -  History of abnormal vaginal bleeding of unknown cause&#xD;
&#xD;
          -  Untreated or uncontrolled high blood pressure/hypertension&#xD;
&#xD;
          -  Use of any medication or supplement containing estrogen, progestin, SERM, St. John's&#xD;
             Wort, bisphosphonates, or phytoestrogens&#xD;
&#xD;
          -  History of hormone-associated migraines&#xD;
&#xD;
          -  History of deep vein thrombosis (blood clots), thrombophlebitis, or thromboembolic&#xD;
             disorders&#xD;
&#xD;
          -  Participation in a clinical trial within 30 days&#xD;
&#xD;
          -  Abnormal endometrial biopsy or mammogram&#xD;
&#xD;
          -  Abnormal transvaginal ultrasound defined as &gt;7mm thickness&#xD;
&#xD;
          -  Vegan&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stacie Geller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology University of Illinois, Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <study_first_submitted>August 4, 2003</study_first_submitted>
  <study_first_submitted_qc>August 4, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2003</study_first_posted>
  <last_update_submitted>October 11, 2007</last_update_submitted>
  <last_update_submitted_qc>October 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2007</last_update_posted>
  <keyword>menopause</keyword>
  <keyword>hot flashes</keyword>
  <keyword>red clover</keyword>
  <keyword>black cohosh</keyword>
  <keyword>sexual dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

